Indian pharma stocks up on report US taps drugmakers for critical cancer drug
23/06/2026 06:14
BUZZ-Indian pharma stocks up on report US taps drugmakers for critical cancer drug ** Shares of Indian pharma companies .NIPAHRM gain 1.8%
** US FDA has reached out to Indian drugmakers for a critical cancer drug ifosfamide which is in short supply due to manufacturing disruptions in US, Mint reports citing sources
** Drug regulator sends SOS to Indian Drug Manufacturers' Association to identify potential manufacturers capable of supplying ifosfamide, report adds
** All but one of 20 stocks on sub-index in green with gains led by Piramal Pharma's PIRM.NS 9.8% jump
** Cipla CIPL.NS and Alkem Laboratories ALKE.NS rise ~2% each
** US FDA and IDMA did not immediately respond to Reuters requests for comment
** YTD, pharma index up 10.8% vs Nifty 50's .NSEI 7.7% decline
(Reporting by Kashish Tandon in Bengaluru)
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees